Neuroprotective effect of pseudoginsenoside-F11 on a rat model of Parkinson's disease induced by 6-hydroxydopamine

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Jian Yu ^a   Yang, Jing Yu ^a   Wang, Fang ^a   Fu, Shi Yuan ^a   Hou, Yue ^a   Jiang, Bo ^a   Ma, Jie ^a   Song, Cui ^a   Wu, Chun Fu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893720473     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/152798     Document Type: Article

References (43)

1. Kabuto H., Yamanushi T. T., Effects of zingerone [4-(4-hydroxy-3- methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced parkinson's disease mouse model. Neurochemical Research 2011 36 12 2244 2249 2-s2.0-80755139522 10.1007/s11064-011-0548-5
2. Blandini F., Neural and immune mechanisms in the pathogenesis of Parkinson's disease. Journal Neuroimmune Pharmacology 2013 8 1 189 201
3. Hirsch E. C., Jenner P., Przedborski S., Pathogenesis of Parkinson's disease. Movement Disorders 2013 28 1 24 30
4. Kabuto H., Yamanushi T. T., Janjua N., Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model. Journal of Oleo Science 2013 62 1 21 28
5. Koppula S., Kumar H., More S. V., Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease. Molecules 2012 17 10 11391 11420
6. Venkateshappa C., Harish G., Mythri R. B., Mahadevan A., Srinivas Bharath M. M., Shankar S. K., Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease. Neurochemical Research 2012 37 2 358 369 2-s2.0-84856372105 10.1007/s11064-011-0619-7
7. Nikam S., Nikam P., Ahaley S. K., Sontakke A. V., Oxidative stress in Parkinson's disease. Indian Journal of Clinical Biochemistry 2009 24 1 98 101 2-s2.0-65649106909 10.1007/s12291-009-0017-y
8. Huang M., Liu W., Li Q., Chun F. W., Endogenous released ascorbic acid suppresses ethanol-induced hydroxyl radical production in rat striatum. Brain Research 2002 944 1-2 90 96 2-s2.0-0037135114 10.1016/S0006-8993(02)02722-1 (Pubitemid 34775012)
9. Singh N., Pillay V., Choonara Y. E., Advances in the treatment of Parkinson's disease. Progress in Neurobiology 2007 81 1 29 44 2-s2.0-33847105184 10.1016/j.pneurobio.2006.11.009 (Pubitemid 46282270)
10. Van Kampen J., Robertson H., Hagg T., Drobitch R., Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Experimental Neurology 2003 184 1 521 529 2-s2.0-0345257309 10.1016/j.expneurol.2003.08.002 (Pubitemid 37444059)
11. Youdim K. A., Joseph J. A., A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radical Biology and Medicine 2001 30 6 583 594 2-s2.0-0035868503 10.1016/S0891-5849(00)00510-4 (Pubitemid 32280784)
12. Chen X.-C., Zhu Y.-G., Zhu L.-A., Huang C., Chen Y., Chen L.-M., Fang F., Zhou Y.-C., Zhao C.-H., Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. European Journal of Pharmacology 2003 473 1 1 7 2-s2.0-0038825258 10.1016/S0014-2999(03)01945-9 (Pubitemid 36851622)
13. Wang C. M., Liu M. Y., Wang F., Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease. Pharmacology Biochemistry and Behavior 2013 106 57 67
14. Li Z., Wu C. F., Pei G., Guo Y. Y., Li X., Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice. Pharmacology Biochemistry and Behavior 2000 66 3 595 601 2-s2.0-0033934591 10.1016/S0091-3057(00)00260-4 (Pubitemid 30440856)
15. Li Z., Xu N.-J., Wu C.-F., Xiong Y., Fan H.-P., Zhang W.-B., Sun Y., Pei G., Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary- cells. NeuroReport 2001 12 7 1453 1456 2-s2.0-0035946834 (Pubitemid 32476146)
16. Wu C. F., Liu Y. L., Song M., Liu W., Wang J. H., Li X., Yang J. Y., Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice. Pharmacology Biochemistry and Behavior 2003 76 1 103 109 2-s2.0-1642378970 10.1016/S0091-3057(03)00215-6 (Pubitemid 38366172)
17. Hao Y., Yang J. Y., Wu C. F., Wu M. F., Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice. Pharmacology Biochemistry and Behavior 2007 86 4 660 666 2-s2.0-34249712470 10.1016/j.pbb.2007.02.011 (Pubitemid 46829319)
18. Li Z., Guo Y. Y., Wu C. F., Li X., Wang J. H., Protective effects of pseudoginsenoside-F11 on scopolamine-induced memory impairment in mice and rats. Journal of Pharmacy and Pharmacology 1999 51 4 435 440 2-s2.0-0033035270 10.1211/0022357991772484 (Pubitemid 29248320)
19. Mo J., Zhang H., Yu L.-P., Sun P.-H., Jin G.-Z., Zhen X., L-Stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiology of Aging 2010 31 6 926 936 2-s2.0-77951974540 10.1016/j.neurobiolaging.2008.06.017
20. Capper-Loup C., Frey C. M., Rebell D., Kaelin-Lang A., Adaptive gene expression changes on the healthy side of parkinsonian rats. Neuroscience 2013 233 157 165
21. Khuwaja G., Khan M. M., Ishrat T., Ahmad A., Raza S. S., Ashafaq M., Javed H., Khan M. B., Khan A., Vaibhav K., Safhi M. M., Islam F., Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies. Brain Research 2011 1368 254 263 2-s2.0-78651068527 10.1016/j.brainres.2010.10.023
22. Khan M. M., Ahmad A., Ishrat T., Khan M. B., Hoda M. N., Khuwaja G., Raza S. S., Khan A., Javed H., Vaibhav K., Islam F., Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Research 2010 1328 139 151 2-s2.0-77950594327 10.1016/j.brainres.2010.02.031
23. Wu C. F., Bertorelli R., Sacconi M., Pepeu G., Consolo S., Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiology of Aging 1988 9 4 357 361 2-s2.0-0024159509 (Pubitemid 19262067)
24. Sun J. Y., Yang J. Y., Wang F., Wang J. Y., Song W., Su G. Y., Dong Y. X., Wu C. F., Lesions of nucleus accumbens affect morphine-induced release of ascorbic acid and GABA but not of glutamate in rats. Addiction Biology 2011 16 4 540 550 2-s2.0-80053035381 10.1111/j.1369-1600.2010.00244.x
25. Sun J.-Y., Yang J.-Y., Wang F., Hou Y., Dong Y.-X., Wu C.-F., GABAA receptors in VTA mediate the morphine-induced release of ascorbic acid in rat nucleus accumbens. Brain Research 2011 1368 52 58 2-s2.0-78651068826 10.1016/j.brainres.2010.10.029
26. Liu W., Wu C. F., Huang M., Xiao K., Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats. Brain Research 2000 869 1-2 31 38 2-s2.0-0034733787 10.1016/S0006-8993(00)02345-3 (Pubitemid 30345772)
27. Teixeira M. D., Souza C. M., Menezes A. P., Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats. Pharmacology Biochemistry and Behavior 2013 110C 1 7
28. Blum D., Torch S., Lambeng N., Nissou M.-F., Benabid A.-L., Sadoul R., Verna J.-M., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Progress in Neurobiology 2001 65 2 135 172 2-s2.0-0034993599 10.1016/S0301-0082(01)00003-X (Pubitemid 32524182)
29. Decressac M., Mattsson B., Björklund A., Comparison of the behavioural and histological characteristics of the 6-OHDA and α -synuclein rat models of Parkinson's disease. Experimental Neurology 2012 235 1 306 315 2-s2.0-84859889965 10.1016/j.expneurol.2012.02.012
30. Schober A., Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell and Tissue Research 2004 318 1 215 224 2-s2.0-5544229693 10.1007/s00441-004-0938-y (Pubitemid 39366054)
31. Henderson J. M., Watson S., Halliday G. M., Heinemann T., Gerlach M., Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. Behavioural Brain Research 2003 139 1-2 105 113 2-s2.0-0037450073 10.1016/S0166-4328(02)00087-6 (Pubitemid 36298496)
32. Sánchez-Iglesias S., Méndez-Álvarez E., Iglesias-González J., Muñoz-Patiño A., Sánchez-Sellero I., Labandeira-García J. L., Soto-Otero R., Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease. Journal of Neurochemistry 2009 109 3 879 888 2-s2.0-64149110856 10.1111/j.1471-4159.2009. 06019.x
33. +) into the striatum is associated with hydroxyl free radical generation. Brain Research 2001 906 1-2 170 175 2-s2.0-0035816351 10.1016/S0006-8993(01)02238-7 (Pubitemid 32595552)
34. Sachs C., Jonsson G., Mechanisms of action of 6-hydroxydopamine. Biochemical Pharmacology 1975 24 1 1 8 2-s2.0-0016411549
35. Perumal A. S., Gopal V. B., Tordzro W. K., Cooper T. B., Cadet J. L., Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Research Bulletin 1992 29 5 699 701 2-s2.0-0026446062 10.1016/0361-9230(92)90142-K
36. Kumar R., Agarwal A. K., Seth P. K., Free radical-generated neurotoxicity of 6-hydroxydopamine. Journal of Neurochemistry 1995 64 4 1703 1707 2-s2.0-0028916715
37. Andrew R., Watson D. G., Best S. A., Midgley J. M., Wenlong H., Petty R. K. H., The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochemical Research 1993 18 11 1175 1177 2-s2.0-0027331917 10.1007/BF00978370 (Pubitemid 23306353)
38. Blandini F., Armentero M.-T., Martignoni E., The 6-hydroxydopamine model: news from the past. Parkinsonism & Related Disorders 2008 14 2 S124 S129 2-s2.0-47049116273 10.1016/j.parkreldis.2008.04.015
39. Rice M. E., Ascorbate regulation and its neuroprotective role in the brain. Trends in Neurosciences 2000 23 5 209 216 2-s2.0-0034194081 10.1016/S0166-2236(99)01543-X (Pubitemid 30236180)
40. Vatassery G. T., In vitro oxidation of vitamin E, vitamin C, thiols and cholesterol in rat brain mitochondria incubated with free radicals. Neurochemistry International 1995 26 5 527 535 2-s2.0-0029072803 10.1016/0197-0186(94)00147-M
41. Harrison F. E., May J. M., Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radical Biology and Medicine 2009 46 6 719 730 2-s2.0-60449102448 10.1016/j.freeradbiomed.2008.12.018
42. 2 signaling. Neuron Glia Biology 2004 1 4 365 376
43. Lin W.-M., Zhang Y.-M., Moldzio R., Rausch W.-D., Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. Journal of Neural Transmission, Supplementa 2007 72 105 112 2-s2.0-38449083961 10.1007/978-3-211-73574-9-13